T. Bavaro*a,
M. Filice*b,
C. Temporinia,
S. Tengattinia,
I. Serraa,
C. F. Morellic,
G. Massolinia and
M. Terrenia
aDepartment of Drug Sciences and Italian Biocatalysis Center, University of Pavia, via Taramelli 12, I-27100 Pavia, Italy. E-mail: teodora.bavaro@unipv.it
bDepartamento de Biocatalisis, Instituto de Catalisis (ICP-CSIC), Marie Curie 2 Cantoblanco Campus UAM, 28049 Madrid, Spain. E-mail: marco.filice1@gmail.com
cDepartment of Chemistry and Italian Biocatalysis Center, University of Milano, via Golgi 19, I-20133 Milano, Italy
First published on 23rd October 2014
In this paper a series of 2-iminomethoxyethyl mannose-based mono- and disaccharides have been synthesized by a chemoenzymatic approach and used in coupling reactions with ε-amino groups of lysine residues in a model protein (ribonuclease A, RNase A) to give semisynthetic neoglycoconjugates. In order to study the influence of structure of the glycans on the conjugation outcomes, an accurate characterization of the prepared neoglycoproteins was performed by a combination of ESI-MS and LC-MS analytical methods. The analyses of the chymotryptic digests of the all neoglycoconjugates revealed six Lys-glycosylation sites with a the following order of lysine reactivity: Lys 1 ≫ Lys 91 ≅ Lys 31 > Lys 61 ≅ Lys 66. A computational analysis of the reactivity of each lysine residue has been also carried out considering several parameters (amino acids surface exposure and pKa, protein flexibility). The in silico evaluation seems to confirm the order in lysine reactivity resulting from proteomic analysis.
Chemical routes to the synthesis of neoglycoproteins can involve random or site-selective modifications of protein surface expecting the final covalent linkage of the glycans via their reducing end interposed by a reactive spacer.1,6 Usually, methods used for the synthesis of neoglycoproteins permit to conjugate the carbohydrate to a protein by the alkylation of nucleophilic side chains of cysteine or lysine residues.2,7,8 Cysteine-based chemical ligation has been significantly used to fully synthesize several neoglycoproteins8 and in some cases the incorporation, by site-directed mutagenesis, of one reactive cysteine residue as a chemoselective tag at a preselected position within the given protein was requested.9 A different strategy, known as indiscriminate glycosylation, relies on the use of 2-iminomethoxyethyl thioglycosides (IME) and takes advantage from the high abundance of lysine residues on the protein surface, allowing the introduction of various saccharide units for each molecule of protein.8 For example, Pearce and co-workers employed this methodology to incorporate up to 20000 glycan moieties onto the surface of adenovirus.10 Although firstly introduced about 30 years ago, this simple and well-established method can now be revalued in vaccine development in order to strengthen immune response by the use of polyantigenic glycoconjugates prepared with a carrier protein bearing a high number of lysines.11 A high glycosylation degree can also be useful in order to improve the therapeutic efficiency of bioactive proteins, but, in this case also the area of the protein responsible of the biological activity could be involved in the chemical modification.
The coupling reaction between oligosaccharides and a protein by a non-selective glycosylation approach, allows the formation of different randomly modified glycoforms, including the possible glycosylation of areas of the protein surface associated with its biological activity. This implies the need of a detailed characterization of the conjugation products.
In addition to the complex analysis required for the characterization of glycoconjugates, it should be also considered that the development of new drugs based on complex structures such as neoglycoproteins is still hampered by the complex multi-step strategies required for sugar preparation. Nowadays, different approaches are available to facilitate the access to pure oligosaccharides, such as the automated solid-phase synthesis.2,12 Alternative enzymatic or chemoenzymatic approaches has also gained popularity because of intrinsic properties of the biocatalysts. In this vein, the lipase-assisted chemoenzymatic synthesis of biologically relevant di- and trisaccharides has been recently reported.13–15
In this work, we propose a useful multidisciplinary approach for a rapid preparation and analytical characterization of complex neoglycoproteins obtained by indiscriminate glycosylation of lysine ε-amino groups of ribonuclease A (RNase A), selected as model protein. For the synthesis of the reactive glycans used for conjugation with the protein, the enzymatic regioselective deprotection of peracetylated mannopyranose derivatives 1–3 has been studied. The compound 3 carries a thiocyanomethyl group at the C-1 position as precursor of the reactive IME. The products 3a,b obtained by hydrolysis of the thiocyanomethyl mannopyranoside 3 have been then considered as intermediates for the synthesis of peracetylated dimannopyranoside and arabino-mannopyranosides 5, 6 and 8, according to the general chemoenzymatic strategy previously reported.13–15 The final IME-saccharides (9–12) have been used for the glycosylation of RNase A. Flow Injection Analysis (FIA) of intact glycoproteins by MS is generally carried out to establish product identity and integrity of natural glycoproteins, as well as to assess the relative abundance of individual glycoforms.16–18 In this work, this MS analytical approach has been used also for the characterization of the neoglycoproteins in order to determine the number and position of glycans introduced. Accordingly, the glycosylation degree was monitored by direct infusion of intact proteins in a linear ion trap mass spectrometer (ESI-LIT-MS), while a detailed characterization of glycosylation sites and their relative abundance was performed by liquid chromatography-mass spectrometry peptide mapping after an appropriate proteolytic cleavage of the synthesised neoglycoproteins. Moreover, a computational study of the reactivity of the different lysines on the RNase A surface has been performed. The in silico evaluation of selected physico-chemical parameters that could correlate with the reactivity of the different glycosylation sites (lysines) on the protein surface, could be useful tools for the design, preparation and characterization of neoglycoconjugates.
In this work, peracetylated mannose and derivatives thereof have been thus subjected to enzymatic hydrolysis, in order to obtain carbohydrate moieties bearing only one free hydroxyl group in specific positions. The obtained compounds have been then used as key building blocks for the synthesis of mannose-based disaccharides. First, the hydrolyses of the peracetylated α-mannopyranoside (1) (Scheme 1), catalyzed by different lipases adsorbed on hydrophobic support, were studied (Table S1, see ESI†).
Among all the enzymes tested (lipases from Candida rugosa, Pseudomonas fluorescens, Aspergillus niger, Pseudomonas cepacia, Pancreas porcine and Rhizomucor miehei), only the lipase from Candida rugosa (CRL) showed both a good activity and a useful selectivity, affording 1,2,3,4-tetra-O-acetyl-α-D-mannopyranoside (1a), deriving from the hydrolysis of the acetyl group at the 6 position, as the only product, according to the results previously obtained with other pyranoses.13–15 The catalytic performances of the other enzymes tested were negligible (data not shown) and, consequently, CRL was selected as the biocatalyst for the hydrolysis of acetylated α-O-methyl mannopyranoside (2) and 1-thio-(S-cyanomethyl)-α-mannopyranoside (3).
CRL, adsorbed onto two supports with different grade of hydrophobicity such as octyl-sepharose (OAg) or decaoctyl-sepabeads (ECOD),22 afforded different results depending on the substrate (Table S1, see ESI†). Great differences can be observed in term of selectivity, depending on the functional group linked at the anomeric position of the sugar (acetoxy, methoxy or thiocyanomethyl group). In particular, a complete selectivity was achieved toward the primary position when 1 and 2 were used as substrate, while the presence of thiocyanomethyl group at the anomeric position strongly influenced the regioselectivity. In fact, when compound 3 was subjected to enzymatic hydrolysis, 2,3,4-tri-O-acetyl-1-thio-(S-cyanomethyl)-α-D-mannopyranoside 3a (deprotected at the C-6 position) together with 3,4,6-tri-O-acetyl-1-thio-(S-cyanomethyl)-α-D-mannopyranoside 3b (deprotected at the C-2 position) were obtained in almost equal amounts (Scheme 1 and Table S1†) In addition, the selected biocatalyst (CRL-ECOD) resulted completely stable after five cycles (Fig. S1, see ESI†).
The hydrolysis of substrate 3 was scaled up to 1.65 L affording 2.2 g and 1.8 g of products 3a and 3b, respectively. The C-6 and C-2 monodeprotected products 3a and 3b were used as building blocks to prepare the saccharides 5, 6 and 8 (Scheme 2) by Schmidt glycosylation reaction (Lewis acid-catalyzed glycosylation using glycosyl trichloroacetimidate as the donor).13
The reaction was optimized with respect to nature and concentration of glycosylation promoter, time and temperature (Table S2, see ESI†) and the acetylated thiocyanomethyl disaccharides Man(1-6)Man (5) and Ara(1-6)Man (6) were obtained in 70% and 62% yields, respectively using the mild Lewis acid boron trifluoride etherate as the promoter (Scheme 2). The synthesis of the peracetylated disaccharide Ara(1-2)Man (8) required instead the use of the stronger promoter tert-butyldimethylsilyl trifluoromethanesulfonate, to afford product 8 in 50% yield (Table S2†).
Compounds 3, 5, 6 and 8 were subsequently submitted to Zemplén deacetylation reaction23 with the double purpose to remove the acetyl esters protecting groups and to functionalize the C-1 position as 2-iminomethoxyethyl (IME) group in single a synthetic step (Scheme 3). In all the cases, the IME-saccharides 9–12 were obtained in about 50% yield, as evaluated by ESI-MS.
Conjugation of these glycans was performed with the commercially available ribonuclease A (124 amino acids, molecular mass 13.681 Da) containing 10 Lys residues (Fig. 1 and Scheme 3).
Fig. 1 Surface analysis and localization of Lys residues belonging to each monomer of RNase A dimer. |
First, the reaction of Man-IME (9) with RNase A was studied as a model reaction in order to optimize the experimental conditions for the formation of a covalent bond involving the ε-amino groups of the lysine residues (Table 1). The effects of the buffer, pH and temperature on the reaction outcomes have been investigated through ESI-MS analyses carried out by direct infusion (see Experimental section).
Entry | T (°C) | pH | Buffer | N incorporated Man (% relative abundance) | Mannose bound/protein (mol/mol) | Conversion (%) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | ||||||
1 | 37 | 8 | Na2B4O7 | 15 | 35 | 25 | 16 | 7 | 1 | — | — | 1.7 | 85 |
2 | 37 | 8.5 | Na2B4O7 | 5 | 16 | 29 | 26 | 16 | 7 | 1 | — | 2.6 | 95 |
3 | 37 | 9.5 | Na2B4O7 | 7 | 19 | 29 | 24 | 15 | 5 | 1 | — | 2.4 | 93 |
4 | 37 | 10.5 | Na2B4O7 | 42 | 38 | 20 | — | — | — | — | — | 0.8 | 58 |
5 | 37 | 9.5 | Na2CO3 | 6 | 9 | 28 | 29 | 20 | 8 | — | — | 2.7 | 94 |
6 | 25 | 9.5 | Na2B4O7 | — | 3 | 11 | 18 | 25 | 20 | 14 | 9 | 4.0 | 100 |
The nature of the buffer and the temperature seem to poorly influence the outcome of the reaction (Entries 1–3, 5 and 6). On the contrary, surprisingly increasing the pH from 9.5 to 10.5 resulted in a strong reduction of the yield from 94% to 58% of the glycosylated protein (Entries 3 and 4), while a decrease of pH value below 9.0 poorly influenced the amount of conjugated protein.
The neoglycoprotein 13 is composed of a mixture of glycoforms with a common peptide backbone but bearing a different number of sugar units. In particular, the most abundant glycoforms are those bearing two or three mannose units (Table 1). The glycosylation of RNase was also performed with activated disaccharides 10–12 at the optimal reaction conditions (Na2B4O7 buffer, pH 9.5, 37 °C) (Table 2).
Reagent | Product | N incorporated glycan (% relative abundance) | Glycan bound/protein (mol/mol) ± SD | Conversion (%) ± SD | ||||||
---|---|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 5 | 6 | ||||
9 | 13 | 7 | 19 | 29 | 24 | 15 | 5 | 1 | 2.3 ± 0.3 | 93 ± 3 |
10 | 14 | 8 | 24 | 27 | 21 | 14 | 6 | — | 2.3 ± 0.0 | 92 ± 3 |
11 | 15 | 9 | 21 | 31 | 24 | 11 | 4 | — | 2.2 ± 0.1 | 91 ± 2 |
12 | 16 | 21 | 39 | 27 | 13 | — | — | — | 1.3 ± 0.1 | 78 ± 6 |
Generally, the glycosylation yields ranged between excellent (93% for Man-IME 9) and good reaction yields (78% for Ara(1-2)Man-IME 12). These values were calculated as the ratio between of the sum of the relative abundance of all the glycoforms over the total ions, including the non-glycosylated protein (Table 2). Under a qualitative point of view, the glycosylation profiles varied depending on the glycoside used. In particular, when the monosaccharide 9 was used, the glycosylation ratio (the number of saccharides bound to each molecule of RNase) was 2.3. Similar results have been obtained with IME-disaccharides 9–11, while a lower ratio (about 1.0) was observed when Ara(1-2)Man-IME (12) was used as the glycosylating agent (Table 2). In the last case, the presence of a glycosidic bond in position C-2 of mannose seems to reduce the efficiency of the reaction, probably as a consequence of a steric hindrance.
In order to have a direct evidence of the exact positions where the observed multi-site glycosylation has occurred and a quantitative estimate of the glycosylation relevance at each site, all the neoglycoproteins were hydrolyzed by chymotrypsin and the released glycopeptides were selectively extracted, separated and identified by ESI-MSn. In detail, glycopeptides were selectively enriched by on-line SPE on hypercarb trap column (PGC-online SPE), and subsequently separated on an Amide 80 column by HILIC-MS/MS. The obtained results (Fig. 2) indicate that the vast majority of conjugation reactions implicate those lysine residues not implicated in the interface of the dimeric form of the protein (Fig. 1), regardless the glycan used. This result confirms that RNase A in solution is mainly present in the dimeric complex. Indeed, only a minor part (<10%) of lysine residues included in the interface of the dimeric aggregate, namely K98 and K104, react with mannose and other glycans, as probable consequence of the reaction of a minor portion of monomeric protein in equilibrium with the dimeric form.
The most reactive area of the protein (almost 40% of glycosylated form) involved K1/K7 amino group. Unfortunately, the glycopeptide obtained by enzymatic digestion contains two Lys residues and the generated MS2 and MS3 spectra did not allow to unambiguously identify the actual glycosylation site. However, taken together the evidences on which the K7 looks on to the dimeric interface (Fig. 1), it might be assumed that the lysine conjugated with the glycans is the K1.
The other positions involved in the reactions are almost equally distributed (about 20% each) among K91 and K31, while a minor amount of RNase was found to be glycosylated at K61-K66.
Interestingly, the same reactivity order of surface lysines was observed when RNase was coupled with either mono- or disaccharides (9–12), notwithstanding the lower glycosylation extent reached with the latter, markedly evident with Ara(1-2)Man-IME 12 (Table 2).
Finally, in attempt to modulate the reactivity of the different lysine residues, the conjugation reaction with Man-IME was performed at lower pH value (8.5 and 8). Reducing the pH of the reaction medium from 9.5 to 8, an improvement of the reactivity of K1 from 40% up to 55% of the total conjugated lysines was observed, while reducing below the 20% the glycosylation extent of K91 which was the second residue in reactivity order (Fig. 3).
Fig. 3 Glycosylation sites involved in conjugation reaction of IME-Man (9) with RNase A at different pH values. |
To this scope, various critical parameters have been considered: intermolecular protein–protein interactions, multimeric conformations or tendency to aggregation in solution, solvent accessibility for each amino acid side chain, flexibility of different surface area and ionization of the reactive amino acids. By using the PDB structure, we assessed of the probable conformation in solution using the Protein Interfaces, Surfaces and Assemblies (PISA) service at the European Bioinformatics Institute (https://www.ebi.ac.uk/pdbe/pisa/). The results showed a tendency of this protein to assembly in a dimeric form in solution. The monomeric form of RNase A exhibited on its surface all lysine residues (Fig. S2, see ESI†). However, only few of them (K1, K31, K61, K66 and K91) were completely exposed on the area of the protein external at the interface (Fig. 1) while others lysines are placed at the limit of the protein surface involved in the dimeric complex, and thus, probably poorly exposed towards the reaction medium. Accordingly, the accessible surface area (ASA) of the different lysines has been analysed including also the amino acids involved in the interface between the two monomers.26 With the combined PISA and ASA analyses a ranking of the different lysines related to their surface exposition has been obtained. As reported in Fig. 4 and S3 (see ESI†), the most accessible Lys resulted the K1, followed by K66 ≈ K91 > K61 ≈ K98 > K31.
Fig. 4 Analysis of the solvent accessibility (ASA) of the lysines of RNase A (PDB code 1FS3). |
Fig. 5 reports the pKa analysis of the Lys of the protein. The lowest pKa values are comprised between 8 and 8.5 (K41 and K66). It is noteworthy that, in the dimeric form of the protein, for K66 the pKa value decrease from about 10.5 in the monomeric form to about 8.5 in the dimer. Another important parameter to be considered is the protein flexibility. In fact, protein structure varies among different conformations defined by the amino acidic backbone, and the more flexible zones could theoretically better react during a chemical modification.
Thanks to the analysis of flexibility in biomolecules and networks service it is possible to estimate the space of vibration for each residues. The results obtained in this analysis suggest that the most flexible areas of RNase are centered on the residues 66–70, 1, 88–93 and 30–39 of the protein sequence (Fig. 6). Especially the first residue range comprised between amino acids 66–70 showed a great fluctuation variation up to 17 Å2. Accordingly to the evaluation this parameter the most reactive lysine residues could be outlined (K1, K66, K61, K91 or K31).
Fig. 6 Flexibility analysis of RNase A structure (PDB: 1FS3) [http://biocomp.chem.uw.edu.pl/CABSflex/]. (a) Fluctuation variation of entire protein sequence, (b) Fluctuation variation ranked by amino acids. |
The spectra were deconvoluted with Bioworks Browser (Thermo Electron, revision 3.1). The identities of ribonuclease A and its glycoforms were assigned on the basis of the average molecular weight in the deconvoluted spectra and their relative abundance determined by the relative intensities of the corresponding peaks.
Glycopeptides were identified on the basis of fragmentation ions in MS2 and MS3 spectra by in silico screening with Bioworks Browser (Thermo Electron, revision 3.1) setting the glycan moieties as optional modifications of lysine residues. Only the identification with a X-corr greater than 1 were consider and to avoid false positive MS2 and MS3 spectra of all species recognized as glycopeptides were manually confirmed.
For quantitative measurements, the area of each glycopeptide was determined by integrating the peak in the respective single ion current chromatogram.
1H NMR (400 MHz, CDCl3): δ = 5.48 (d, J = 1.4 Hz, 1H, H-1), 5.39 (dd, J = 3.2, 1.6 Hz, 1H, H-2), 5.35–5.21 (m, 5H, H-4′, H-3′, H-2′, H-4, H-3), 4.85 (d, 1H, J = 1.4 Hz, H-1′), 4.29–4.25 (m, H-5, 2H, H-6A), 4.13 (dd, J = 11.2, 6.1 Hz, 1H, H-6B), 4.05–4.00 (m, 1H, H-5′), 3.85 (dd, J = 11.6, 6.8 Hz, 1H, H-6′B), 3.58 (dd, J = 11.6, 3.2 Hz, 1H, H-6′A), 3.54 (d, J = 17.3 Hz, 1H, HA SCH2CN), 3.36 (d, J = 17.3 Hz, 1H, HB SCH2CN), 2.19 (s, 3H), 2.16 (s, 3H), 2.11 (s, 3H), 2.08 (s, 3H), 2.06 (s, 3H), 2.00 (s, 3H) and 1.99 (s, 3H), CH3COO.
13C NMR (101 MHz, CDCl3): δ = 170.20, 170.03, 169.97, 169.86, 169.68 (CH3COO), 115.74 (SCH2CN); 97.36 (C-1′), 81.55 (C-1), 70.63 (C-5), 69.56 (C-2), 69.46 (C-3′), 69.08 (C-3), 68.97 (C-5′), 66.52 (C-4), 66.21 (C-6), 65.87 (C-4′), 62.51 (C-6′), 21.01, 20.94, 20.85, 20.81, 20.71 (CH3COO), 15.47 (SCH2CN).
MS: m/z = 714.29 [M + Na]+ (calcd 714.63). |
1H-NMR (400 MHz; CDCl3): δ = 5.45 (d, J = 1.4 Hz, 1H, H-1), 5.34 (dd, J = 3.5, 1.4 Hz, 1H, H-2), 5.30 (dd J = 9.8, 9.8 Hz, 1H, H-4), 5.24 (ddd, J = 3.5, 3.5, 1.7 Hz, 1H, H-4′), 5.20 (dd, J = 9.8, 3.5 Hz, 1H, H-3), 5.17 (dd, J = 9.2, 6.7 Hz, 1H, H-2′), 5.04 (dd, J = 9.2, 3.5 Hz, 1H, H-3′), 4.51 (d, J = 6.7 Hz, 1H, H-1′), 4.24 (ddd J = 9.8, 6.5, 2.4 Hz, 1H, H-5), 4.04 (dd, J = 13.0, 3.5 Hz, 1H, H-5′A), 3.96 (dd, J = 11.7, 6.5 Hz, 1H, H-6A), 3.66 (dd, J = 11.7, 2.4 Hz, 1H, H-6B), 3.62 (dd, J = 13.0, 1.7 Hz, 1H, H-5′B), 3.54 (d, J = 17.2 Hz, 1H, HA SCH2CN), 3.28 (d, J = 17.2 Hz, 1H, HB SCH2CN), 2.17 (s, 3H), 2.13 (s, 3H), 2.09 (s, 3H), 2.06 (s, 3H), 2.04 (s, 3H) and 1.99 (s, 3H), CH3COO.
13C-NMR (101 MHz; CDCl3): δ = 170.46, 170.30, 169.99, 169.87, 169.70 and 169.58, CH3COO, 116.04 (SCH2CN), 100.78 (C-1′), 81.50 (C-1), 70.94 (C-5), 70.05 (C-3′), 69.74 (C-2), 69.53 (C-3), 69.15 (C-2′), 67.60 (C-4′), 66.88 (C-6), 66.47 (C-4), 63.23 (C-5′), 21.08, 21.00, 20.89 and 20.80, CH3COO, 15.22 (SCH2CN).
MS: m/z = 642.33 [M + Na]+ (calcd 642.58). |
1H-NMR (400 MHz; CDCl3): δ = 5.59 (d, J = 1.3 Hz, 1H, H-1), 5.30 (t, J = 10.0 Hz, 1H, H-4), 5.28–5.24 (m, 2H, H-4 and H-4′), 5.04 (dd, J = 3.2, 1.2 Hz, 1H, H-3), 5.02 (dd, J = 3.0, 1.3 Hz, 1H, H-3′), 4.43 (dd, J = 12.5, 4.0 Hz, 1H, H-6A), 4.38 (d, J = 7.0 Hz, 1H, H-1′), 4.25(ddd, J = 10.1, 4.0, 2.0 Hz, 1H, H-5), 4.16 (dd, J = 3.2, 1.3 Hz, 1H, H-2), 4.14–4.09 (m, 2H, H-2 and H-6B), 4.02 (dd, J = 13.1, 3.1 Hz, 1H, H-5′A), 3.59 (dd, J = 13.1, 1.6 Hz, 1H, H-5B), 3.45 (d, J = 17.2 Hz, 1H, HA CH2CN), 3.30 (d, J = 17.2 Hz, 1H, HB CH2CN), 2.17 (s, 3H), 2.16 (s, 3H), 2.15 (s, 3H), 2.07 (s, 3H), 2.04 (s, 3H) and 2.03 (s, 3H), CH3COO.
13C-NMR (101 MHz; CDCl3): δ = 171.03, 170.43, 170.38, 170.20, 169.69 and 169.38 (CH3COO), 116.05 (SCH2CN), 102.65 (C-1′), 84.45 (C-1), 76.30 (C-2), 71.34 (C-3), 69.87 (C-3′), 69.80 (C-5), 68.75 (C-2′), 67.51 (C-4), 65.63 (C-4′), 63.55 (C-5′), 61.56 (C-6), 29.84, 21.08, 20.87 and 20.76 (CH3COO), 16.02 (SCH2CN).
MS: m/z = 642.50 [M + Na]+ (calcd 642.58). |
Man-IME (9) MS: m/z = 290.33 [M + Na]+ (calcd 290.29). |
Man(1-6)Man-IME (10) MS: m/z = 452.75 [M + Na]+ (calcd 452.64). |
Ara(1-6)Man-IME (11) MS: m/z = 422.33 [M + Na]+ (calcd 422.40). |
Ara(1-2)Man-IME (12) MS: m/z = 422.33 [M + Na]+ (calcd 422.40). |
The possibility to drive the conjugation with glycans toward defined areas of the protein surface can be very important in case of antigenic and other bioactive proteins, in order to avoid modification of the residues involved in the biological activity. To this scope and to widen the possible application areas, studies involving antigenic protein structures are ongoing.
Footnote |
† Electronic supplementary information (ESI) available: Regioselective hydrolysis of acetylated mannopyranosydes 1–3 catalyzed by immobilized Candida rugosa lipase. Glycosylation study for the synthesis of disaccharides 5, 6 and 8 at different reaction conditions. Different cycles of hydrolysis reaction of compound 3 catalyzed by CRL-ECOD. Analysis of the solvent accessibility (ASA) of the amino acids of RNase A (PDB code 1FS3). Surface analysis and localization of Lys residues of RNase A in monomeric form. 1H and 13C NMR spectra of disaccharides 5, 6 and 8. ESI-MS deconvoluted spectra of neoglycoproteins 13–16. List of glycopeptides identified by LC-ESI-MSn from chymotryptic digestion of 13–16. See DOI: 10.1039/c4ra11131a |
This journal is © The Royal Society of Chemistry 2014 |